从“肺与大肠相表里”浅谈COVID-19肺肠同治

Discussion on the Treatment of COVID-19 Lung Intestine from “Lung and Large Intestine”

摘要: COVID-19自爆发以来，经过社会各界人士的共同努力，虽然目前病情传播已经得到了一定程度的控制，但仍然缺乏针对性的特效药物治疗。中医学认为加强患者肠道管理对重症肺炎的治疗和预后具有很重要的作用，中医药在胃肠道管理和治疗方面独具优势并且具有深厚的理论根源。本文基于“肺与大肠相表里”的理论基础，通过研究古代及现代理论、认识COVID-19的特点以及胃肠道症状的防治等，说明“肺炎从肠论治”或为减轻体内SARS-CoV-2感染、减少轻症转化为重症、减少死亡率、增加治愈率的一种途径。

Abstract: Since the outbreak of COVID-19, through the joint efforts of people from all walks of life, although the disease has been spread to a certain degree of control, there is still a lack of specific drug treatment. Traditional Chinese medicine holds that strengthening the intestinal management of patients plays an important role in the treatment and prognosis of severe pneumonia. In this paper, based on the theoretical basis of “lung and large intestine”, by studying ancient and modern theories, understanding the characteristics of COVID-19 and the prevention and treatment of ga-strointestinal symptoms, etc., this paper illustrates the “treatment of pneumonia from the intestine” or a way to reduce the in vivo SARS-CoV-2 infection, reduce the mild disease into severe disease, reduce the death rate, and increase the cure rate.